These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2444955)

  • 1. Adenocarcinoma of the canine prostate: immunohistochemical examination for secretory antigens.
    McEntee M; Isaacs W; Smith C
    Prostate; 1987; 11(2):163-70. PubMed ID: 2444955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostatic specific antigen: immunoreactivity in urachal remnants.
    Golz R; Schubert GE
    J Urol; 1989 Jun; 141(6):1480-2. PubMed ID: 2470928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
    Purnell DM; Heatfield BM; Trump BF
    Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple immunoperoxidase markers in benign hyperplasia and adenocarcinoma of the prostate.
    Ellis DW; Leffers S; Davies JS; Ng AB
    Am J Clin Pathol; 1984 Mar; 81(3):279-84. PubMed ID: 6199966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation of prostate-specific antigen expression in different tumour growth patterns present in prostatectomy specimens.
    Gallee MP; Visser-de Jong E; van der Korput JA; van der Kwast TH; ten Kate FJ; Schroeder FH; Trapman J
    Urol Res; 1990; 18(3):181-7. PubMed ID: 1697709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.
    Ersev A; Ersev D; Turkeri L; Ilker Y; Simsek F; Kullu S; Akdas A
    Prog Clin Biol Res; 1990; 357():129-34. PubMed ID: 1699237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study on expression of prostatic inhibin peptide, prostate acid phosphatase and prostate specific antigen in androgen independent human and rat prostate carcinoma cell lines.
    Garde SV; Sheth AR; Porter AT; Pienta KJ
    Cancer Lett; 1993 Jul; 70(3):159-66. PubMed ID: 7689036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder.
    Lane Z; Hansel DE; Epstein JI
    Am J Surg Pathol; 2008 Sep; 32(9):1322-6. PubMed ID: 18670358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands.
    Abrahamsson PA; Lilja H; Falkmer S; Wadström LB
    Prostate; 1988; 12(1):39-46. PubMed ID: 2450341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical application of prostatic markers. I. Classification of prostatic tumours using immunohistochemical techniques.
    Svanholm H; Hørder M
    Scand J Urol Nephrol Suppl; 1988; 107():65-70. PubMed ID: 2453920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-specific antigen testing in untreated and treated prostatic adenocarcinoma.
    Rainwater LM; Morgan WR; Klee GG; Zincke H
    Mayo Clin Proc; 1990 Aug; 65(8):1118-26. PubMed ID: 1697014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of prostatic acid phosphatase (PSAP) in transurethral resection specimens of the prostate is predictive of histopathologic tumor stage in subsequent radical prostatectomies.
    Gunia S; Koch S; May M; Dietel M; Erbersdobler A
    Virchows Arch; 2009 May; 454(5):573-9. PubMed ID: 19301031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in immunohistochemical staining in prostatic adenocarcinoma following diethylstilbestrol therapy.
    Grignon D; Troster M
    Prostate; 1985; 7(2):195-202. PubMed ID: 2413432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in immunohistochemical staining of PSA, PAP, and TURP-27 following irradiation therapy for clinically localized prostate cancer.
    Grob BM; Schellhammer PF; Brassil DN; Wright GL
    Urology; 1994 Oct; 44(4):525-9. PubMed ID: 7524238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is prostate-specific antigen the most useful marker for screening in prostate cancer?
    Delaere KP; Van Dieijen-Visser MP; Gijzen AH; Brombacher PJ
    Am J Clin Oncol; 1988; 11 Suppl 2():S65-7. PubMed ID: 2468276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.
    Stamey TA; Yang N; Hay AR; McNeal JE; Freiha FS; Redwine E
    N Engl J Med; 1987 Oct; 317(15):909-16. PubMed ID: 2442609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor associated glycoprotein-72 is highly expressed in prostatic adenocarcinomas.
    Myers RB; Meredith RF; Schlom J; LoBuglio AF; Bueschen AJ; Wheeler RH; Stockard CR; Grizzle WE
    J Urol; 1994 Jul; 152(1):243-6. PubMed ID: 8201675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical demonstration of tumor-associated antigens in prostatic carcinomas of various histological differentiations.
    Friedmann W; Steffens J; Lobeck H; Blümcke S; Nagel R
    Eur Urol; 1985; 11(1):52-6. PubMed ID: 2580711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunohistochemical identification of specific prostatic phosphatases and specific prostatic antigen in prostatic tumors].
    Bonetti F; Pisa R; Chilosi M; Loddo G; Menestrina F; Zamboni G; Pea M
    Pathologica; 1983; 75(1040):789-95. PubMed ID: 6201809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.